US 12076324
Cancer treatments using combinations of CDK and ERK inhibitors
granted A61KA61K31/4439A61K31/506
Quick answer
US patent 12076324 (Cancer treatments using combinations of CDK and ERK inhibitors) held by Biomed Valley Discoveries, Inc. expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Biomed Valley Discoveries, Inc.
- Grant date
- Tue Sep 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K31/4439, A61K31/506, A61K31/519, A61K45/06